Hyundai Pharmaceutical Co., Ltd. (004310.KS) KSC

3,765.00

-25(-0.66%)

Updated at October 24 03:30PM

Currency In KRW

Valuation

Market Cap91.46B
Enterprise Value129.26B
P/E Ratio-48.79
PEG Ratio8.39
Price/Sales Ratio0.54
Price/Book Ratio1.25
Enterprise/Revenue0.78
Enterprise/EBITDA82.57

Fiscal Year

Fiscal YearNovember 30, 2024
Most Recent QuarterMay 31, 2025

Profitability

Profit Margin-0.01
Operating Margin-0.01

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.03

Income Statement

Revenue175.74B
Revenue/Share6,985.77
Gross Profit73.37B
EBITDA3.94B
Net Income-574.89M
Diluted EPS-22.41

Balance Sheet

Total Cash4.93B
Total Cash/Share190.9
Total Debt47.96B
Total Debt/Equity0.61
Current Ratio1.11
Book Value Per Share3,017.1

Price History

52-Week Change-3.09
52-Week High4,890
52-Week Low2,995
Moving Average 50 Days3,897.3
Moving Average 200 Days3,581.08

Statistics

Average Volume459,140
Shares Outstanding26.14M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate30
Trailing Annual Dividend Yield0.8
Payout Ratio0
Last Split Factor513:500
Last Split DateOctober 20, 2017